These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36534127)

  • 1. The immunogenetics of COVID-19.
    Srivastava A; Hollenbach JA
    Immunogenetics; 2023 Jun; 75(3):309-320. PubMed ID: 36534127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Variation and SARS-CoV-2 Specific Antibody Response.
    Wolday D; Fung CYJ; Morgan G; Casalino S; Frangione E; Taher J; Lerner-Ellis JP
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
    Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease.
    Hosseini E; Minagar A; Ghasemzadeh M; Arabkhazaeli A; Ghasemzadeh A
    Hum Immunol; 2023 Apr; 84(4):263-271. PubMed ID: 36822912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; López-Ruz MÁ; Martín-Casares AM; Fernández-Rubiales A; Anderson P; Garrido F; Ruiz-Cabello F; López-Nevot MÁ
    J Microbiol Immunol Infect; 2022 Jun; 55(3):421-427. PubMed ID: 34475005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2.
    Jin X; Liu X; Shen C
    Virus Res; 2023 Jan; 324():199024. PubMed ID: 36526016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential haplotype expression in class I MHC genes during SARS-CoV-2 infection of human lung cell lines.
    Francisco Junior RDS; Temerozo JR; Ferreira CDS; Martins Y; Souza TML; Medina-Acosta E; de Vasconcelos ATR
    Front Immunol; 2022; 13():1101526. PubMed ID: 36818472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual
    Schetelig J; Heidenreich F; Baldauf H; Trost S; Falk B; Hoßbach C; Real R; Roers A; Lindemann D; Dalpke A; Kolditz M; de With K; Bornhäuser M; Bonifacio EE; Rücker-Braun E; Lange V; Markert J; Barth R; Hofmann JA; Sauter J; Bernas SN; Schmidt AH
    Front Immunol; 2021; 12():698193. PubMed ID: 34381451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in patients with renal replacement therapy.
    Akcay OF; Yeter HH; Unsal Y; Yasar E; Gonen S; Derici U
    Hum Immunol; 2023 Apr; 84(4):272-277. PubMed ID: 36797091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
    Mentzer AJ; O'Connor D; Bibi S; Chelysheva I; Clutterbuck EA; Demissie T; Dinesh T; Edwards NJ; Felle S; Feng S; Flaxman AL; Karp-Tatham E; Li G; Liu X; Marchevsky N; Godfrey L; Makinson R; Bull MB; Fowler J; Alamad B; Malinauskas T; Chong AY; Sanders K; Shaw RH; Voysey M; ; Snape MD; Pollard AJ; Lambe T; Knight JC
    Nat Med; 2023 Jan; 29(1):147-157. PubMed ID: 36228659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted capture enrichment and sequencing identifies HLA variants associated with the severity of COVID-19.
    Liu C; Zhang L; Chen J; Gao Y
    Genes Genomics; 2023 Apr; 45(4):451-456. PubMed ID: 36574143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
    Zhang Y; Chen Y; Li Y; Huang F; Luo B; Yuan Y; Xia B; Ma X; Yang T; Yu F; Liu J; Liu B; Song Z; Chen J; Yan S; Wu L; Pan T; Zhang X; Li R; Huang W; He X; Xiao F; Zhang J; Zhang H
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34021074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.
    Nagler A; Kalaora S; Barbolin C; Gangaev A; Ketelaars SLC; Alon M; Pai J; Benedek G; Yahalom-Ronen Y; Erez N; Greenberg P; Yagel G; Peri A; Levin Y; Satpathy AT; Bar-Haim E; Paran N; Kvistborg P; Samuels Y
    Cell Rep; 2021 Jun; 35(13):109305. PubMed ID: 34166618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.
    Kiyotani K; Toyoshima Y; Nemoto K; Nakamura Y
    J Hum Genet; 2020 Jul; 65(7):569-575. PubMed ID: 32372051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA class I with severe acute respiratory syndrome coronavirus infection.
    Lin M; Tseng HK; Trejaut JA; Lee HL; Loo JH; Chu CC; Chen PJ; Su YW; Lim KH; Tsai ZU; Lin RY; Lin RS; Huang CH
    BMC Med Genet; 2003 Sep; 4():9. PubMed ID: 12969506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks.
    La Porta CAM; Zapperi S
    Cell Syst; 2020 Oct; 11(4):412-417.e2. PubMed ID: 32916095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
    Migliorini F; Torsiello E; Spiezia F; Oliva F; Tingart M; Maffulli N
    Eur J Med Res; 2021 Aug; 26(1):84. PubMed ID: 34344463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance between COVID-19 and host genetics of immune response.
    Taher I; Almaeen A; Ghazy A; Abu-Farha M; Mohamed Channanath A; Elsa John S; Hebbar P; Arefanian H; Abubaker J; Al-Mulla F; Alphonse Thanaraj T
    Saudi J Biol Sci; 2021 Nov; 28(11):6645-6652. PubMed ID: 34305429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ancestral origins are associated with SARS-CoV-2 susceptibility and protection in a Florida patient population.
    Shen Y; Khatri B; Rananaware S; Li D; Ostrov DA; Jain PK; Lessard CJ; Nguyen CQ
    PLoS One; 2023; 18(1):e0276700. PubMed ID: 36649279
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.